SynthesisDiabetes technology & therapeutics2015

Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.

Feng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.